NCT07616128招募中2 期
A Randomized, Double-Blind, Placebo Controlled Study Evaluating the Efficacy and Safety of EVO756 for the Prevention of Migraine in Adults
适应症
干预措施
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 330
- 试验地点
- 34
研究概览
简要总结
This study will evaluate the efficacy and safety of EVO756 against placebo in adults with migraine.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 64 Years(Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adults aged 18 to <65 years
- •Migraine with or without aura, per ICHD-3 criteria
- •History of failure with prior preventive migraine treatments
- •Not currently using migraine preventive therapy
排除标准
- •Difficulty distinguishing migraine from other headache types or presence of other primary headache disorders
- •Use of certain medications
- •Any clinically significant medical, psychiatric, neurological, cardiovascular, or laboratory abnormalities
研究组 & 干预措施
Dose 1
Experimental
Orally administered EVO756, Dose 1 (Daily)
干预措施: EVO756, Dose 1 (Drug)
Dose 2
Experimental
Orally administered EVO756, Dose 2 (Daily)
干预措施: EVO756, Dose 2 (Drug)
Placebo
Placebo Comparator
Placebo control (Daily)
干预措施: Placebo (Drug)
研究者
研究点 (34)
Loading locations...
相似试验
尚未招募
2 期
A STUDY ON EPIPHEGUS VIRGINIANA 30C TO REDUCE DISABILITY CAUSED BY MIGRAINECTRI/2025/11/098000Dr Sanha36
招募中
2 期
Effectiveness of Pankajakasthuri Migraine Oil in Reducing Migraine Headache Symptoms Among Adults: A Clinical StudyCTRI/2024/11/076378Pankajakasthuri Herbals India Pvt Ltd60
招募中
3 期
A Study to Learn About the Efficacy and Safety of Rimegepant for the Acute Treatment of Migraine in Children and Adolescents.2024-512743-23-00Pfizer Inc.155
尚未招募
不适用
Study compares Propranolol and Metoprolol for migraine prophylaxis in a hospital trial.CTRI/2024/09/073430Dr Ramizahmad Maiyuddinbhai Mansuri80
尚未招募
不适用
Study of Diet and regimen along with homoeopathic management of migraineCTRI/2024/10/075323Dr.Divya Misra30
